Guardant Health director Azar Alex M II exercised Options for 1,651 shares at $0 on 2026-09-12. For investors, the transaction left him with 1,651 shares and 4,953 derivative securities, while the exercise represented about 100.0% of his resulting share holding and 25.0% of his prior derivative securities holding.
Key Highlights
- The transaction was recorded on 12 September 2026 under SEC transaction code M.
- Azar Alex M II held 4,953 derivative securities after the exercise.
- The transaction represented about 100.0% of resulting shares and 25.0% of prior derivative securities.
Guardant Health, Inc. (NASDAQ: GH) director Azar Alex M II exercised options for 1,651 shares at $0 per share on 12 September 2026.
Option Exercise Recorded on September 12
Azar Alex M II’s resulting share holding was 1,651 shares. His post-transaction derivative securities holding was 4,953. The record identifies the exercise as involving both shares and derivative securities.
Reported Holdings Show Different Ownership Bases
The exercise represented about 100.0% of Azar Alex M II’s resulting share holding. It also represented about 25.0% of his prior derivative securities holding.
FAQs
Q: What did the Guardant Health director exercise?
A: Guardant Health director Azar Alex M II exercised options for 1,651 shares at $0 per share on 12 September 2026. The transaction used code M.
Q: What was the impact on Azar Alex M II’s Guardant Health holdings?
A: Azar Alex M II held 1,651 Guardant Health shares after the exercise and 4,953 derivative securities. The transaction represented about 100.0% of resulting shares.
Q: What does the 25.0% figure represent?
A: The 25.0% figure represents the portion of Azar Alex M II’s prior derivative securities holding associated with the transaction. His post-transaction derivative securities holding was 4,953.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.